Health & Biotech Stock Insiders: NGS are reaching new heights with a clinically tested nutritional supplement May 13, 2022 Nutritional Growth Solutions is a global nutritional health company, working to ensure children reach their potential height. Incannex shares reach a high of 44c on landmark $125m deal to buy US cannabinoid pioneer APIRx May 12, 2022 Special Report: Incannex shares have rocketed higher today on news it has signed a formal deal to buy out APIRx… ASX Health Stocks: Race and Rhythm make their moves to advance Australian share May 12, 2022 ASX health stock Race Oncology has been given governance approval for the lead site of its clinical trial of Zantrene… Check Up: Is biotech a good investment in a higher rate cycle? Turns out theory is just a theory May 12, 2022 A study explores the correlation between higher rates and biotech stock prices And also High Cap vs Low Cap biotechs… PharmAust expands canine trial of Monepantel to the US, expediting the close out of Phase 2 study May 11, 2022 Special Report: The expansion of the canine trial of Monepantel to the US comes after successful earlier trials in both… ASX Health Stocks: Integral goes big in Queensland, Credit Suisse says it’s time to choose between HLS and ACL May 11, 2022 IDX snaps up QLD-based radiology group for circa $38m, NSB starts HREC review process, and Credit Suisse downgrades HLS. Bone specialist Osteopore secures key ANZ distribution as it targets oral & maxillofacial surgery May 10, 2022 Special Report: Osteopore has signed a key distribution deal in Australia and New Zealand as it moves to gain a… Knocking heads: Incannex achieves key concussion breakthrough May 10, 2022 Special Report: IHL’s novel drug IHL-216A could be the holy grail in concussion treatment, with promising preclinical study results showing… ASX Health Stocks: Ecstasy for Emyria in MDMA trial, Beamtree wins US$7m deal May 10, 2022 Emyria announced progress on its MDMA (ecstasy) program Imugene gets green light for a Phase 2 Australian clinical trial Beamtree… ASX Health Stocks: Artrya goes to America while EZZ goes live on TikTok China May 9, 2022 Artrya signs first partnership in the US as it looks to commercialise EZZ Life Sciences sets up a store on… Next» « Previous